4729 |
Intravascular Imaging-guided Complex PCI: Which One and Why? |
Do-Yoon Kang |
Apr. 19. 24 |
4728 |
How to Define Complex PCI in Your PCI Practice |
Mamas Mamas |
Apr. 19. 24 |
4727 |
Renal Safety Issues in Dyslipidemia Treatment: Why is it Important? |
Duk-Woo Park |
Apr. 19. 24 |
4726 |
Early Benefit of Lipitor in ACS Patients |
Sripal Bangalore |
Apr. 19. 24 |
4725 |
Beyond the Initial Event: Long-Term Management with Antiplatelet Therapy |
Choongki Kim |
Apr. 19. 24 |
4724 |
Navigating Acute Coronary Syndrome: Effective De-escalation Strategies |
Osung Kwon |
Apr. 19. 24 |
4723 |
High-dose Atorvastatin and Ezetimibe Combination for Treatment of Dyslipidemia Patients with ASCVD |
Gyu-Chul Oh |
Apr. 19. 24 |
4722 |
Recent Trends and Clinical Evidence for Optimizing Lipid Management : A Focus on Ezetimibe Combination Therapy |
Ju Yeol Baek |
Apr. 19. 24 |
4721 |
A Resolution to the Next Frontier |
Pinakin Vijaykumar Parekh |
Apr. 19. 24 |
4720 |
Why Do I Love to Use DCB? Case Based Story |
Jong-Young Lee |
Apr. 19. 24 |